Double Lumen OPU Needle: Technical Value And Industrial Standardization in The Mild IVF Era

1. Industry and Clinical Pain Points of Traditional Single-Lumen OPU Technology

The global assisted reproductive industry is undergoing a profound shift from traditional high-stimulation, high-yield IVF to personalized mild IVF and natural-cycle treatment models. Different from conventional IVF protocols that induce 8–15 follicles with high-dose drugs, mild stimulation and natural-cycle schemes only produce 1–6 follicles, forming a "zero-margin" clinical treatment scenario. Under this trend, the defects of traditional single-lumen OPU aspiration needles have become increasingly prominent, restricting the improvement of mild IVF clinical success rates. Designed for high-throughput egg retrieval scenarios, single-lumen needles rely on one-time high-pressure aspiration, which easily collapses small antral follicles of less than 10 mm in diameter. In mild IVF cycles, oocyte-cumulus complexes (COC) are tightly adhered to the granulosa cell wall through cumulus fibers and hyaluronic acid-rich matrix. Single-lumen needle suction often fails to separate adherent COCs completely, resulting in missed oocyte retrieval. Unlike high-yield conventional IVF, where individual egg loss can be statistically offset, the loss of a single oocyte in mono-follicular natural cycles directly leads to cycle cancellation. In addition, thick-gauge single-lumen needles cause obvious follicle wall bleeding during puncture, and blood stains will further obscure tiny follicle structures, increasing the difficulty of secondary retrieval. Traditional single-lumen technology lacks targeted adaptive solutions for low-follicle mild IVF scenarios, resulting in high cycle cancellation rates, repeated drug stimulation, increased patient economic burden and emotional pressure, and forming a major bottleneck for the standardized promotion of mild IVF.

2. Working Principle of Double-Lumen Needle Precision Retrieval Technology

The double-lumen OPU needle solves the clinical pain points of mild IVF through innovative "second-chance engineering" precision retrieval logic, realizing adaptive matching with low-follicle and small-follicle treatment scenarios. The core technical principle lies in the integrated design of independent flushing and aspiration lumens, which separates follicle cavity expansion and oocyte retrieval operations. For small antral follicles with adherent COCs, the double-lumen system adopts an intermittent warm flushing mode: it injects a 0.5 mL constant-temperature (37–37.5°C) medium bolus into the atrium to re-expand the collapsed follicle cavity. The tangentially offset flushing jet gently loosens the cumulus fiber connection between the COC and granulosa wall, effectively separating adherent oocyte complexes while minimizing zona pellucida shear damage. After a 2-second static stabilization, low-pressure aspiration (80–110 mmHg) is used for precise retrieval of freed COCs. Matched with the optimized 18G/19G triple-cut bevel structure, the needle body achieves ultra-sharp and low-trauma puncture, greatly reducing follicle wall bleeding and avoiding visual obstruction caused by intraoperative hemorrhage. Different from the high-throughput retrieval logic of traditional needles, the double-lumen technology abandons the goal of maximizing egg yield and focuses on zero loss of individual oocytes, forming a precise retrieval mechanism exclusive to mild IVF.

3. Classification and Scenario Matching of Double-Lumen OPU Needle Products

According to clinical protocol types, follicle quantity and surgical scenario differences, double-lumen (DL) OPU needles form a complete graded matching system, realizing full coverage of differentiated assisted reproductive scenarios. First, 17G single-lumen needles are only applicable to conventional antagonist protocols with 8–15 follicles, with double-lumen equipment reserved only for suspected empty follicle auxiliary retrieval. Second, 18G double-lumen needles are the mainstream model for mild stimulation protocols with 3–6 follicles, adopting selective intermittent flushing to balance retrieval precision and efficiency. Third, 18–19G ultra-fine double-lumen needles are specially used for natural mono-follicular cycles, limiting single flushing volume to 0.5 mL and a maximum of two flushes to ensure ultra-gentle operation and protect oocyte activity. Fourth, 16G thick-gauge double-lumen needles are customized for donor egg retrieval and viscous follicle fluid scenarios, adopting simultaneous flushing and suction strategies to improve retrieval efficiency. In addition, customized PTFE long-size double-lumen needles are developed for veterinary equine reproductive scenarios with special anatomical structures. This hierarchical product classification completely solves the scenario mismatch problem of traditional single-specification needles and forms a professional equipment system for refined IVF treatment.

4. Standardized Gentle-OPU Operating Guidelines for Double-Lumen Needles

To maximize the precision advantages of double-lumen needles in mild IVF, a set of standardized whole-process gentle operation specifications has been formulated to regulate clinical operation details. Preoperative preparation: warm the flushing medium to a constant temperature of 37–37.5°C consistent with human body temperature, and exhaust bubbles completely to avoid follicle cavity stimulation and oocyte damage. Needle selection: adopt 18G needles for conventional mild cycles and 19G ultra-fine needles for follicles smaller than 10 mm, and confirm the echo-tip positioning effect under ultrasound before needle insertion. Intraoperative operation: complete one-time stable puncture without repeated probing and in-and-out adjustment; aspirate continuously for 2 seconds at 90–110 mmHg, and pause immediately if no COC is obtained. Perform 0.5 mL medium bolus flushing, hold for 2 seconds, and conduct a slight probe sweep within 10 degrees to loosen adherent tissues, then re-aspirate at a low pressure of 80 mmHg, with a maximum of two flushing operations in a single cycle. Postoperative processing: release negative pressure suction completely before needle withdrawal, and deliver the follicle fluid sample to embryologists within 60 seconds to ensure timely oocyte detection. Preoperative patient counseling is standardized to inform patients that gentle retrieval takes 2–3 extra minutes, eliminating misunderstandings of low efficiency and improving patient cooperation.

5. Multi-Center Clinical Practical Data and Application Experience

Joint clinical data from three professional mild IVF centers (total sample size n≈340) fully verify the excellent clinical value of double-lumen needle technology. After replacing traditional 17G single-lumen needles with 18G double-lumen needles equipped with selective intermittent flushing strategies, the zero-oocyte cycle cancellation rate dropped significantly from 9.1% to 4.4%, greatly improving the success rate of mild IVF treatment. In natural mono-follicular cycles, the application of 19G ultra-fine double-lumen needles reduced postoperative vaginal spotting and pelvic discomfort complaints by nearly 40%, with significantly reduced surgical trauma and improved patient experience. Embryological evaluation shows that COC cumulus cell integrity and morphological stability retrieved by double-lumen needles are far better than those of single-lumen needles, providing higher-quality oocyte resources for subsequent fertilization and embryo culture. Clinical practical experience also confirms a key applicable rule: double-lumen precision retrieval relies on stable and patient operation, and rushed flushing and high-speed retrieval will completely offset its technical advantages, which is the core key to standardizing clinical promotion.

6. Benefit Analysis and Value Sublimation of Double-Lumen Technology

The popularization of double-lumen OPU needle technology brings dual improvements in economic benefits and medical ethics for mild IVF treatment. In terms of cost performance, mild IVF itself reduces high-dose drug costs compared with traditional protocols, while double-lumen technology effectively avoids cycle cancellation caused by oocyte loss. Calculated based on 200 annual natural cycles in a single center, the 4–5% reduction in zero-oocyte cancellation rates can avoid 8–10 repeated stimulation treatments every year, saving a large amount of repeated drug costs and time costs for patients, with extremely high return on investment. In terms of medical ethics, the 2–3 minutes of extended gentle operation is not inefficient treatment, but a deliberate medical choice to protect oocyte integrity and cycle success rate. Standardized informed consent interpretation reframes patient cognition, distinguishes "gentle precision treatment" from "slow operation", effectively rebuilds patient trust in assisted reproductive technology, and realizes the humanized sublimation of clinical medical services. From an industrial perspective, double-lumen technology promotes the transformation of OPU surgery from industrial high-throughput retrieval to personalized precision retrieval, matching the core development trend of modern reproductive medicine.

7. Industry Regulatory Trends and Future Development Prospects

At present, the clinical application specifications of double-lumen needles have risen from industry preference to standardized medical norms. Many national reproductive medicine associations have clearly stipulated that natural-cycle OPU standard operating procedures must adopt needles of ≤18G and standardized selective flushing strategies, accelerating the phase-out of traditional single-lumen thick-gauge needles. Looking forward to 2030, the mild IVF OPU industry will build a full set of precision surgical systems dominated by 19G double-lumen needles, matched with portable ramp pressure pumps, AI tiny follicle probe navigation technology and LIMS single-egg retrieval automatic archiving system. As the core connecting technology between high-throughput traditional OPU and modern precision OPU, double-lumen needle technology will continue to drive the standardized, auditable and humanized upgrading of the assisted reproductive industry. It is suggested that medical institutions fully popularize graded double-lumen needle matching schemes, update SOP specifications, and strengthen clinical doctor training on gentle flushing and low-pressure retrieval to further release the technical advantages and social value of precision mild IVF treatment.